Literature DB >> 19805457

Recommendations for screening, monitoring, and referral of pediatric chronic hepatitis B.

Barbara A Haber1, Joan M Block, Maureen M Jonas, Saul J Karpen, W Thomas London, Brian J McMahon, Karen F Murray, Michael R Narkewicz, Philip Rosenthal, Kathleen B Schwarz.   

Abstract

Most children with chronic hepatitis B virus infection (persistent hepatitis B surface antigen-positive for >6 months) are asymptomatic and do not generally require treatment. These children are, however, at increased risk for severe complications later in life, including advanced liver disease and liver cancer. On November 11, 2008, the Hepatitis B Foundation, a nonprofit research and disease advocacy organization, convened a panel of nationally recognized North American pediatric liver specialists to consider and recommend an approach for the screening, monitoring, initial management, and referral of children with chronic hepatitis B. The panel developed recommendations to provide guidance to practitioners on determining what additional tests to conduct, how often to monitor on the basis of test results, and when to refer to a pediatric liver specialist to build a partnership between the practitioner and liver specialist to enhance the success of management of children with this lifelong infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19805457     DOI: 10.1542/peds.2009-0567

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  14 in total

1.  Chronic hepatitis B in children in the United States and Canada: international origins place the disease burden on children even in the era of universal vaccination.

Authors:  Haruki Komatsu; Ayano Inui
Journal:  Transl Pediatr       Date:  2016-01

Review 2.  Hepatitis B and C.

Authors:  Wikrom Karnsakul; Kathleen B Schwarz
Journal:  Pediatr Clin North Am       Date:  2017-06       Impact factor: 3.278

3.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

Review 4.  Management of patients with hepatitis B in special populations.

Authors:  Evangelos Cholongitas; Konstantinos Tziomalos; Chrysoula Pipili
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

5.  Phenotypes of Chronic Hepatitis B in Children From a Large North American Cohort.

Authors:  Kathleen B Schwarz; Manuel Lombardero; Adrian M Di Bisceglie; Karen F Murray; Philip Rosenthal; Simon C Ling; Yona Keich Cloonan; Norberto Rodriguez-Baez; Sarah Jane Schwarzenberg; Jay H Hoofnagle; Jeffrey Teckman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-11       Impact factor: 2.839

Review 6.  Chronic hepatitis B in children and adolescents: epidemiology and management.

Authors:  Mona Abdel-Hady; Deirdre Kelly
Journal:  Paediatr Drugs       Date:  2013-08       Impact factor: 3.022

7.  Children with Chronic Hepatitis B in the United States and Canada.

Authors:  Kathleen B Schwarz; Yona Keich Cloonan; Simon C Ling; Karen F Murray; Norberto Rodriguez-Baez; Sarah Jane Schwarzenberg; Jeffrey Teckman; Lilia Ganova-Raeva; Philip Rosenthal
Journal:  J Pediatr       Date:  2015-09-10       Impact factor: 4.406

8.  Prenatal hepatitis B screening, and hepatitis B burden among children, in Ontario: a descriptive study.

Authors:  Mia J Biondi; Alex Marchand-Austin; Kirby Cronin; Natasha Nanwa; Vithusha Ravirajan; Erin Mandel; Lee W Goneau; Tony Mazzulli; Hemant Shah; Camelia Capraru; Harry L A Janssen; Beate Sander; Jordan J Feld
Journal:  CMAJ       Date:  2020-10-26       Impact factor: 8.262

9.  Differential plasma microRNA profiles in HBeAg positive and HBeAg negative children with chronic hepatitis B.

Authors:  Thilde Nordmann Winther; Claus Heiner Bang-Berthelsen; Ida Louise Heiberg; Flemming Pociot; Birthe Hogh
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

10.  Hepatitis B surface antigen quantity positively correlates with plasma levels of microRNAs differentially expressed in immunological phases of chronic hepatitis B in children.

Authors:  Thilde Nordmann Winther; Ida Louise Heiberg; Claus Heiner Bang-Berthelsen; Flemming Pociot; Birthe Hogh
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.